Treatment of autoimmune urticaria with low-dose cyclosporin a: A one-year follow-up

Acta Dermato-Venereologica

Volumn 91, Issue 1, 2011, Pages 50-54

  Boubouka, Christine ^a   Charissi, Christina ^a   Kouimintzis, Dimitris ^a   Kalogeromitros, Dimitris ^a   Stavropoulos, Panagiotis ^a   Katsarou, Alexandra ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Autoimmune diseases; Cyclosporin; Skin tests; Urticaria

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; AUTOIMMUNE URTICARIA; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RELAPSE; SHORT COURSE THERAPY; SYMPTOM; TREATMENT RESPONSE; URTICARIA;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 78751626846     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0939     Document Type: Article

References (26)

1. Greaves MW, Tan KT. Chronic urticaria: recent advances. Clin Rev Allergy Immunol 2007; 33: 134-143.
2. Matthews KP. The urticarias. Current concepts in pathogenesis and treatment. Drugs 1985; 30: 552-560.
3. Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S.Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007; 34: 294-301.
4. Leiste A, Skaletz-Rorowdki A, Venten I, Altmeyer P, Brockmeyer NH. Urticaria associated with Norovirus infection: report of two cases. J Dtsch Dermatol Ges 2008; 6: 563-565.
5. Hachulla E. Les urticaires systemiques. Ann Dermatol Venereol 2003; 130: 553-568.
6. Brunetti L, Francavilla R, Miniello VL, Platzer MH, Rizzi D, Lospalluti ML, et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004; 114: 922-927.
7. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? Curr Opin Allergy Clin Immunol 2005; 5: 403-407.
8. Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, Beri R, et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005; 35: 1599-1607.
9. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-1604.
10. Dodig S, Richter D. Chronic autoimmune urticaria in children. Acta Dermatovenerol Croat 2008; 16: 65-71.
11. Elias J, Boss E, Kaplan AD. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986; 78: 914-918.
12. Ezeamuzie IC, Assem ES. Inhibition of histamine release from human lung and rat peritoneal mast cells by cyclosporine A. Agents Actions 1990; 30: 110-113.
13. Sabroe RA, Grattan CEH, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-453.
14. Dutz JP, Ho CV. Immunosuppressive agents in dermatology. An update. Dermatologic Clinics 1998; 16: 235-251.
15. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465-474.
16. Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F, et al. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002; 128: 59-66.
17. Madan V, Griffiths CEM. Systemic cyclosporine and tacrolimus in dermatology. Dermatologic Therapy 2007; 20: 239-250.
18. Stellato C, dePaulis A, Ciccarelli A. Anti-inflammatory effect of cyclosporine A on human skin mast cell. J Invest Dermatol 1992; 98: 800-804.
19. Kay MM. Autoimmunity and aging. Concepts Immunopathol 1988; 6: 166-192.
20. Tachikawa S, Kawamura T, Kawamura H, Kanda Y, Fujii Y, Matsumoto H, et al. Appearance of B220 low autoantibodyproducing B-1 cells at neonatal and older stages in mice. Clin Exp Immunol 2008; 153: 448-455.
21. Zauli D, Grassi A, Ballardini G, Contestabile S, Zucchini S, Bianchi FB. Thyroid autoimmunity in chronic idiopathic urticaria. Am J Clin Dermatol 2002; 3: 525-528.
22. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66-71.
23. Sadighha A, Shirali R, Mohaghegh Z. Relationship between Helicobacter pylori and chronic urticaria. J Eur Acad Dermatol Venereol 2009; 23: 189-199.
24. Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME. Are autoantibodies present in patients with subacute and chronic urticaria? J Investig Allergol Clin Immunol 2001; 11: 16-20.
25. Inaloz HS, Ozturk S, Akcali C, Kirtak N, Tarakcioglu M. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J Dermatol 2008; 35: 276-282.
26. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P; 0-1-3 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006; 55: 705-709.